L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
REuWvsz7mmKnQQNQ